TNFRSF1A and Miyoshi myopathy: To confirm whether TNFRSF1A is involved in carfilzomib resistance of MM cells, we established the carfilzomib-resistant MM MPC-11 cell line (MPC-11/carfilzomib cells) by exposing the cells to increasing doses of carfilzomib.